Figure 2

Mean change in AM instantaneous total symptom scores for desloratadine 2.5-, 5-, 7.5-, 10-, and 20-mg tablets compared with placebo after the first dose (day 2). Mean changes from baseline are least-square means based on ANOVA model with treatment and center effects. Total symptom score is nasal + nonnasal scores. (^* P < .01 versus placebo.)